反応式
[N:1]1[CH:6]=[CH:5][CH:4]=[N:3][C:2]=1[N:7]1[CH2:12][CH2:11][CH:10]([C:13]([OH:15])=O)[CH2:9][CH2:8]1.O.ON1C2C=CC=CC=2N=N1.Cl.CN(C)CCCN=C=NCC.[C:39]([NH:44][NH2:45])(=[O:43])[CH2:40][CH2:41][CH3:42]>ClCCl.C(=O)([O-])O.[Na+]>[C:39]([NH:44][NH:45][C:13]([CH:10]1[CH2:9][CH2:8][N:7]([C:2]2[N:1]=[CH:6][CH:5]=[CH:4][N:3]=2)[CH2:12][CH2:11]1)=[O:15])(=[O:43])[CH2:40][CH2:41][CH3:42]参加物
反応物 4
生成物 1
試薬・触媒・溶媒 2
実験手順
A mixture of 1-pyrimidin-2-yl-piperidine-4-carboxylic acid (3.0 g, 14.5 mmol)(see reference U.S. Pat. No. 4,826,843), 1-hydroxybenzotriazole hydrate (1.96 g, 14.5 mmol) and 1-(3-dimethylaminopropyl-3-ethylcarbodiimide hydrochloride (2.78 g, 14.5 mmol) in dichloromethane (100 ml) was stirred for 10 minutes. Butyric acid hydrazide (1.78 g, 17.4 mmol) was added and the reaction mixture was stirred under a nitrogen atmosphere for 18 hours. The reaction mixture was diluted with dichloromethane (100 ml) and sodium hydrogen carbonate solution was added. The reaction mixture was concentrated under reduced pressure and the solid formed was isolated by filtration. The material obtained was dried under vacuum at 40° C. to give the title compound (2.62 g).
後処理
- additionwas added
- concentrationThe reaction mixture was concentrated under reduced pressure
- customthe solid formed
- customwas isolated by filtration
- customThe material obtained
- customwas dried under vacuum at 40° C.
出典と根拠
- ORDレコード
- ord-4e299013dbfd48c1bf2a6e7afd13ee69
- 出典データセット
- uspto-grants-2006_08
- 特許番号
- US07084145B2
関連ノート
読み込み中…